Cardiac output (CO) measurement is crucial for the guidance of therapeutic decisions in critically ill and high-risk surgical patients. Newly developed completely non-invasive CO technologies are commercially available; however, their accuracy and precision have not recently been evaluated in a meta-analysis. We conducted a systematic search using PubMed, Cochrane Library of Clinical Trials, Scopus, and Web of Science to review published data comparing CO measured by bolus thermodilution with commercially available non-invasive technologies including pulse wave transit time, non-invasive pulse contour analysis, thoracic electrical bioimpedance/bioreactance, and CO 2 rebreathing. The non-invasive CO technology was considered acceptable if the pooled estimate of percentage error was <30%, as previously recommended. Using a random-effects model, SD, pooled mean bias, and mean percentage error were calculated. An I 2 statistic was also used to evaluate the inter-study heterogeneity. A total of 37 studies (1543 patients) were included. Mean CO of both methods was 4.78 litres min
Key words: cardiac output; meta-analysis Cardiac output (CO) is a fundamental component of oxygen delivery to end organs and is therefore an important variable in adequate management of critically ill and high-risk surgical patients with therapeutic actions (fluid, vasopressor, or inotrope administration). Although its value is beyond dispute for anaesthetists and critical care physicians, this variable has been shown to be undermonitored in clinical settings. 1 Within the last decade, CO has been measured with less invasive methods using newly developed completely non-invasive monitoring devices. Several techniques have emerged recently, such as pulse wave transit time (PWTT) and non-invasive pulse contour analysis (niPCA). These are in addition to older non-invasive approaches, such as thoracic electrical bioimpedance (TEB) and partial CO 2 rebreathing (CO 2 r). Bolus thermodilution (TD) is still the most accepted reference method as there is still no clearly established gold standard for CO measurement in human studies. 2 3 That explains why the accuracy (bias, corresponding to the systematic error between both techniques) and the precision (SD of the bias, corresponding to the random error between both techniques) of CO measurements are usually assessed with a Bland-Altman graph, which does not statistically determine superiority of one device over another. Moreover, the precision of both methods is quantitatively dependent on the value of the mean CO. As a result, percentage of error (PE) has been proposed as an additional measured variable, and is obtained by dividing the 95% confidence interval (CI) of the bias (limits of agreement, LOA) by the mean value of both CO methods. 4 It is important to highlight the fact that successful cardiac output monitoring relies on two things: accuracy of measurements; and the ability to detect short term changes in cardiac output value. However, we decided to focus our metaanalysis on Bland-Altman results because this is the analysis that is now most commonly performed and presented in published method-comparison studies (the trend analysis being less often performed, but equally important).
In 2010, Peyton and Chong 5 conducted a meta-analysis comparing the accuracy and precision of four minimally invasive technologies (calibrated and uncalibrated pulse contour techniques, oesophageal Doppler, CO 2 r and transthoracic bioimpedance) with bolus TD, concluding that none achieved appropriate agreement with bolus thermodilution (PE<30%).
Given that the conclusion was drawn in 2010 and no recent meta-analysis has been performed on the topic (despite two recent contemporary reviews), 2 6 we sought to update the metaanalysis of Peyton and Chong 5 by focusing only on non-invasive CO techniques. As a result, we have included in our metaanalysis PWTT, niPCA, bioimpedance, and CO 2 r technologies (while excluding some minimally invasive or intrusive technologies that were used in the meta-analysis of Peyton and Chong, 5 such as pulse contour monitoring using an a-line, Doppler, or both). Therefore, the goal of this systematic review and meta-analysis was to assess the agreement and precision of completely non-invasive CO monitoring devices against bolus TD. Our objectives were two-fold. Firstly, we systematically reviewed all available studies comparing CO measured with a commercially available and completely non-invasive CO monitoring device (tested method) against bolus TD (reference method) in the operating room (OR), intensive care unit (ICU), and emergency department (ED) as long as they assessed agreement and precision in adults. Secondly, we aimed to conduct a meta-analysis using the extracted data from the systematic review in order to calculate the following four variables: (i) the pooled estimate of the mean difference between the tested and reference method (bias); (ii) the pooled estimate of the SD (precision) of the bias; (iii) the pooled estimate of the 95% CI of the bias (LOA); and (iv) the pooled estimate of the PE. An acceptable agreement between the tested and the reference method was defined as a pooled estimate PE <30%, as previously recommended. 4 
Methods
This systematic review and meta-analysis was conducted following the established guidelines from the 'Preferred Reporting Items for Systematic Reviews and Meta-Analyses' (PRISMA). 7 
Eligibility criteria
We deliberately chose to focus on completely non-invasive CO devices that are commercially available in order for us to compare devices that are easy to use at the bedside by clinicians. Of note, we excluded Doppler-based devices, such as the USCOM and oesophageal Doppler. We made this decision because the USCOM is not a continuous CO monitoring device and the oesophageal Doppler is relatively intrusive when compared with other technologies available. Additionally, as we wanted to focus on non-invasive technologies, we did not include pulse contour monitoring devices (calibrated or uncalibrated), such as the Vigileo Flo Trac, PICCO, and LIDCO systems. Although our patients are completely anaesthetized and there should be no barrier to the use of minimally invasive methods, such as oesophageal Doppler and minimally invasive pulse contour technologies, our meta-analysis focuses on newer technologies that have recently been introduced to the market and not included in recent meta-analyses.
We defined the study eligibility criteria as follows: (i) published manuscripts that compared CO values measured using a commercially available and completely non-invasive CO monitoring device with CO measured by bolus TD (with either transpulmonary or right heart bolus TD); (ii) manuscripts Editor's key points
• Advances in non-invasive cardiac output technologies offer simpler perioperative monitoring, but their accuracy is questioned.
• This meta-analysis found modest agreement and inadequate percentage error for most technologies.
• Novel non-invasive cardiac output technologies are typically developed in relatively healthy populations; their internal algorithms may thus be inappropriate to major surgery or critical illness.
• Percentage error and trending are important variables in the evaluation of non-invasive cardiac output technologies.
documenting extractable biases for CO, SD of the bias or LOA, and PE or reporting sufficient data to calculate PE; (iii) participants must have been adults (age >18 yr) and manuscripts must have reported clear patient characteristics (age, weight, height, sex, setting, sample size, and number of data points collected); and (iv) studies performed in the OR, ICU, or ED. Our exclusion criteria included prototypical technologies and all the conditions that lead to inaccurate measurements of CO by bolus TD; this essentially consisted of any patient population with intracardiac shunts or pulmonary and tricuspid valve insufficiencies. Owing to a lack of funding for translation, we excluded non-English studies except French, as three coauthors are fluent (A.J., O.D., and M.C.). Published data that were not categorized as traditional journal articles (e.g. editorials, letters, and conference papers) were also excluded.
Literature search
We systematically searched the following four databases: PubMed, Scopus (which includes coverage of EMBASE from 1996 to the present) 
Study selection
Initially, three reviewers (A.J., K.S., and O.D.) independently screened eligible studies gathered using the above approach, also known as the eligibility assessment checklist. The second step consisted of assessing every selected study by reading the entire text. The decision to include each study was reached as follows: abstracts were classified as relevant, potentially relevant, or not relevant. Relevant abstracts were selected for a full review of the article (eligibility). Any discrepancy between the three reviewers was resolved with a final decision from the last investigator (M.C.). The flowchart for this study selection process is shown in Fig. 1 . . In order for a study to qualify for inclusion in the analysis, it must have minimally presented a mean bias, the SD of the bias, and the mean PE.
Data-collection process and data items
The percentage error was defined in this meta-analysis as follows:
Percentage error ¼ 1:96 Â SD of bias between both methods ð Þ 0:5 Â Mean non-invasive CO þ mean bolus TD CO ð Þ
If CO was displayed for specific time points only, we calculated the mean CO for the whole study according to the number of data per time plot. If bias and SD or the mean PE was not calculated in this manner, it was recalculated using our definition. Our definition of bias was the value of CO measured using the non-invasive method subtracted from the value of CO measured via bolus TD. When only bias and LOA were documented by a study, SD was then recalculated as follows: upper LOAÀbias)/ 1.96. If necessary for our calculations, we attempted to contact the authors of included studies. Furthermore, we randomly (using a randomizing selection tool from random.org) extracted 10 studies and recalculated the distribution of the bias from the Bland-Altman graph displayed by the authors in order to verify the distribution of the bias (i.e. we scanned the graph, recalculated the y-axis of the coordinates of the plots, with a zero reference as the value of the bias; OOoDigitzer TM , Libreoffice TM , 4.4.2.2, Openoffice.org). Lastly, we reviewed the number of studies assessing CO trending.
Risk of bias in individual studies
The quality of individual studies was assessed according to Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) guidelines, modified in order to be specific for studies of method comparison. This approach was developed and used by our group in previously published meta-analyses on method-comparison studies. [45] [46] [47] O.D., K.S., A.J., and M.C. adjusted the quality assessment form to make it more applicable to this specific meta-analysis. This amended form was used by O.D., A.J., and K.S. to perform quality assessment on each included study. Each manuscript's risk for bias and applicability was systematically classified as low, high, or unclear. At the end of the assessment, the three reviewers met together to obtain the same evaluation for each article.
Summary measures
We defined the various summary measures of our analysis as follows: (i) accuracy of the measured CO monitoring device (defined as the pooled estimate bias between the tested method and the bolus TD method); (ii) pooled estimate precision of the tested CO monitoring device (defined as SD of the bias); (iii) pooled estimate of the LOA (95% CI of the bias); and (iv) the pooled estimate PE. We defined the estimate pooled PE as our primary end point. The PE was considered to be acceptable when <30%, as previously recommended by Critchley and Critchley.
4
Synthesis of the results
Heterogeneity could be present in bias and SD. We therefore used random-effect models to make a synthesis of pooled bias and SD. 48 Pooled PE was calculated as follows:
Heterogeneity of bias and SD for the evaluated studies was calculated using a Q test and described as an I 2 index (25-50%, low heterogeneity; 50-75%, moderate heterogeneity; >75%, high heterogeneity). 49 If moderate or high heterogeneity (I 2 >50%)
was discovered, sensitivity analysis and meta-regression were subsequently performed. As a result, forest plots were created to view and understand the pooled estimate bias with the 95% CI (LOA of the bias).
Risk of publication bias across studies
Publication bias of the included studies was examined using standard funnel plots. These plots represent the bias of CO vs standard error in each study. Egger regression tests were then performed to assess the asymmetry of the Funnel plot using a significance level of 0.1, as the sample size was relatively small. 50 
Additional analysis; meta-bias
To assess the potential influences of study heterogeneity, subgroup analyses were conducted according to several characteristics, as follows: technology of the device; type of the reference method (right heart or transpulmonary bolus TD); tested method (PWTT, niPCA, CO 2 r, or bioimpedance); and setting (OR, ICU, or ORþICU). Additionally, meta-regression analyses were Records excluded (n = 77) = not matching inclusion criteria 
Results

Data retrieval
The initial search resulted in 1646 articles in all languages. A flow diagram outlining the study selection process is provided in Fig. 1 . Of note, among the 37 selected studies, one was split into two different sections (the study by Kotake and colleagues 23 was divided into two different sections in the forest plots and in Table 1 because there were two different versions of the same tested device). It is important to note that 29 articles were excluded for failure to meet our inclusion criteria or insufficient data (Appendix 2).
Study characteristics
A total of 1543 patients were included, with a median of 97 (IQR 36-158) pairs of data per study. The median number of patients was 28 (range . The majority of studies were conducted in perioperative cardiac surgery, with the remaining studies analysing critically ill patients. Of these, 27 studies were conducted in an ICU setting, eight in the OR, and three in both ICU and OR. Parial CO 2 Pulse wave transit time technology corresponded to one technology and one device, the esCCO TM (Nihon Kohden, Tokyo, Japan). Technologies using CO 2 r and TEB were the most represented, followed by niPCA, and then PWTT. Concerning the reference methods, 31 were conducted using right heart TD and seven using transpulmonary TD. Patient characteristics of included studies are shown in Table 1 . The mean CO of the reference method was not cited seven times and its dispersion (SD or IQR) was not cited in 14 instances. The PE was calculated by the authors in 19 instances, and modified in one instance. 33 Three studies, 9 25 40 among the 10 randomly tested, No study clearly stated that bias was normally distributed.
Owing to a lack of abstracted data, 31 authors were contacted, 13 answered, and only eight provided their data.
Subgroup analysis by device type
Lastly, some breakdown of the bioimpedance group into its three components (classic impedance, bioreactance, and velocimetry) was done (see Appendix 3) but did not demonstrate any further differences.
Risk of bias in individual studies
Appendix 4 contains the quality assessment analysis for the included studies (QUADAS-2). In eight studies, flow and timing characteristics presented a high risk of bias.
Synthesis of results
Overall meta-analysis Bias, SD and LOA of the bias, and PE for all included studies are shown in Table 1 
Meta-regression
Declared conflict of interest (P¼0.026) and publication year (P¼0.001) were significantly associated with mean bias (Appendix 6). However, no significant heterogeneity remained after accounting for those factors.
Number of studies presenting a trend analysis
Only 10 studies assessed CO trending, and there was very limited information to perform any additional meta-analysis.
Discussion
Summary of evidence
The main results of this meta-analysis assessing the agreement and precision between non-invasive CO monitoring devices and bolus TD monitoring are as follows: (i) As the PE was similar between minimally invasive and noninvasive devices, the totally non-invasive CO monitors could be an interesting substitute at the bedside. However, further Phase 3 studies (clinical utility/outcome) are clearly mandatory before recommending their widespread use in routine care. 52 Of note, we excluded Doppler-based devices, such as the USCOM and oesophageal Doppler. This was done because the USCOM is not a continuous CO monitoring device and the oesophageal Doppler is relatively intrusive. However, it should be noted that a recent meta-analysis found an equivalent PE for USCOM (43%) when compared with thermodilution. 53 A major limitation of this study, however, is the population selection bias. As we deliberately chose bolus TD as the reference method, this resulted (mostly for ethical reasons) in the vast majority of studies taking place in a cardio-surgical environment or during episodes of haemodynamic instability in critically ill patients. This selection bias has two major consequences. Firstly, the studied population is quite disparate from those whom the non-invasive CO device would most benefit. 54 Certainly, patients undergoing moderate-to high-risk general surgical procedures would have the strongest potential to benefit from these technologies. Importantly, the clear discrepancy between the heterogeneity of this high-risk population (small sample size, with various comorbidities and geographical origin) and the homogeneity of the relatively healthy population used to determine the internal algorithms for calculating non-invasive CO might have biased the validity of the initial CO calibration, which thus increases the potential for disagreement when compared with bolus TD. Secondly, peripheral hypoperfusion commonly seen during proceduress with high amounts of haemodynamic instability or in perioperative cardio-surgical care can decrease the sensitivity of peripheral sensors, specifically via decreasing pulse wave amplitude with niPCA and PWTT. Final CO calculations can therefore become erroneous. This might explain why the PE of niPCA and PWTT are greater than that of CO 2 r and TEB, as both of the latter technologies do not require peripheral pulse wave measurements to determine CO. We established our main objective as the PE in order to assess the degree of agreement between the tested and reference method. This variable depends on the LOA (numerator) and the mean CO of both methods (denominator), although no consensus concerning the mean CO (average of both methods or mean of the reference CO) has been clearly defined. As a result of this definition, PE represents the LOA adjusted to the mean CO and therefore represents the random error between both methods. More Wagner (2015) Hofhuizen (2014) Gerhardt (2000) Fischer ( specifically, it depicts the intrinsic variations of CO that are not linked to true changes of CO, but linked to the environment and the random precision error of both the tested and reference methods. On the contrary, the mean bias depends on the systematic error between both measurements (i.e. the mean constant difference between both methods). When confirming the validity of this approach, one must ensure that the repeatability of bolus TD in the studies is high (precision error <20%). If precision error of the reference method is high, PE will become worthless and acceptability between both techniques will be rejected. This is why Peyton and Chong 5 proposed an increase in the threshold of PE to 45%, allowing for the increased variability noted in bolus TD measurements. All authors in this meta-analysis attempted to reduce the high variability of bolus TD by excluding extreme CO values and recording the average of the three most similar CO measurements. Unfortunately, no observational data presented the dispersion of all TD CO measurements, and only one study assessed the reproducibility of the bolus TD. 42 It could therefore be argued that we should possibly have chosen a different reference technique. However, bolus TD has been considered as the 'gold standard' in other recent meta-analyses. 5 51 Additionally, we do acknowledge that this method is discontinuous, requires manual intervention (therefore increasing the variability of the measure) and is significantly influenced by mechanical ventilation, 55 a caveat which concerns a large proportion of patients in this analysis. Using a reliable continuous CO reference method allows for appropriate interpretation of the PE and therefore should be mandatory for every newly proposed device. In our opinion, ultrasound transit time (USTT) is the most appropriate device tested in in vitro studies. 56 It is worth mentioning that when USTT is used as a reference against bolus TD, CO 2 r, TEB, or a combination of these, the PE is similar between the tested and reference devices (42%), 57 Yamada (2012) Wacharasint ( further confirming the need for additional experimental data before widespread human use can be endorsed.
Only six studies have previously assessed the repeatability of these devices. 13 15 29 35 42 44 When no repeatability assessment has been conducted on both methods, it is impossible to know whether the disagreement between both techniques is attributable to the tested or the reference method. In the context of this lack of adequate data reporting, GRRAS recommendations insist on the reliability and the repeatability reports when a method-comparison study is designed. 58 The limit of describing repeatability is that there are many ways to express it with similar names (reliability, repeatability, or precision error), which can confuse the reader. Similar to the concept of PE (which is now widely used), standardization for the evaluation of repeatability would allow for better spread of this important concept. 59 No included study demonstrated that the bias of any device was normally distributed, although recommended by Bland and Altman. 60 61 The method of pooling data in the meta-analysis is also based on a paramount distribution of the differences, further requiring normality. 48 Of note, three studies randomly chosen in this meta-analysis show a non-normally distributed bias. Bland and Altman 60 proposed using a logarithmic transformation of original data when distribution is found to not be normal, especially when the bias is proportional to the mean difference of both methods. Interestingly, no study included here used this approach. Heterogeneity of the results is highly significant. Unfortunately, it is not explained by subgroup sensitivity analysis (tested device, reference device, or setting) or by meta-regression analysis (number of measurements and patients, value of the bias, LOA, or PE methodological quality of the studies can therefore be a major factor increasing heterogeneity. Once again, sharing individual data could restrict this phenomenon.
Conclusions
We determined that the overall random-effects pooled bias [95% CI] and percentage error were À0,13 [À2.38 , 2.12] litres min -1 and 47%, respectively. Completely non-invasive technologies did not reach an acceptable level of agreement, although minimally invasive technologies present a similar PE. The persistent high heterogeneity after subgroup analysis and meta-regression could be a result of insufficient data reporting and lack of standardization. More rigorous methodology and presentation of method-comparison studies could improve the assessment of consistency and allow physicians to decide better whether non-invasive devices are clinically reliable.
